Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV

The information in the brief version is excerpted directly from the full-text guidelines. The brief version is a compilation of the tables and boxed recommendations.

  •   Table of Contents

Download Guidelines

Appendix B: Panel Roster and Financial Disclosures


Last Updated: February 1, 2016; Last Reviewed: February 1, 2016

Member Financial Disclosure
Company Relationship
Bolan, Gail Centers for Disease Control and Prevention None N/A
Ghanem, Khalil Johns Hopkins University None N/A
Hollier, Lisa Baylor College of Medicine None N/A
Hook, Edward W. 
University of Alabama at Birmingham
Honoraria, Research Support
Gen Probe
Research Support
Research Support
Merck Honoraria
Siemens Research Support
Sena, Arlene University of North Carolina None N/A
Stoner, Brad Washington University School of Medicine None N/A
Workowski, Kim* Emory University Bristol-Myers Squibb Research Support
CDC Consultant
Gilead Consultant
Vertex Research Support

* Group lead

Note: Members were asked to disclose all relationships from 24 months prior to the updated date. The period of reporting was from February 1, 2014, through February 1, 2016.

Download Guidelines